Seeing Is Believing
Currently out of the existing stock ratings of William Tanner, 9 are a HOLD (18.37%), 38 are a BUY (77.55%), 2 are a SELL (4.08%).
Analyst William Tanner, carries an average stock price target met ratio of 53.65% that have a potential upside of 38.35% achieved within 680 days. Previously, William Tanner worked at CANTOR FITZGERALD, GUGGENHEIM, B. RILEY.
William Tanner’s has documented 96 price targets and ratings displayed on 15 stocks. The coverage was on Healthcare, Financial Services sectors.
Most recent stock forecast was given on NVAX, Novavax at 22-Jul-2021.
Analyst best performing recommendations are on SUPN (SUPERNUS PHARMACEUTICALS).
The best stock recommendation documented was for SUPN (SUPERNUS PHARMACEUTICALS) at 4/6/2017. The price target of $31 was fulfilled within 1 day with a profit of $0.8 (2.65%) receiving and performance score of 26.49.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Aug-2025
$16
$7.12 (80.18%)
$11
6 months 19 days ago
(27-Feb-2026)
3/4 (75%)
$5.86 (57.79%)
145
Buy Since 23-Feb-2024
$16
$7.12 (80.18%)
$22
10 months 5 days ago
(10-Nov-2025)
13/39 (33.33%)
$8.89 (125.04%)
100
Hold Since 13-May-2024
$7
$-1.88 (-21.17%)
$8
10 months 11 days ago
(04-Nov-2025)
3/3 (100%)
$-0.51 (-6.79%)
59
Hold Since 14-Jun-2024
$7
$-1.88 (-21.17%)
$9
1 years 26 days ago
(20-Aug-2025)
6/8 (75%)
$-1.74 (-19.91%)
186
Sell Since 17-Jun-2025
$6
$-2.88 (-32.43%)
1 years 2 months 29 days ago
(17-Jun-2025)
0/1 (0%)
$-0.49 (-7.55%)